Skip to main content

Overview of Medical and Surgical Treatment of Severe Obesity

  • Chapter
  • First Online:
Psychiatric Care in Severe Obesity

Abstract

This chapter will explore medical treatments and potential surgical options for treating severe obesity. Medications commonly used for weight loss will be summarized including potential limitations. A brief description of bariatric surgery procedures will be illustrated followed by a summary of the risk-adjusted outcomes as well as rates of improvement of obesity-related comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lau DCW, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. Can Med Assoc J. 2007;176(8 Suppl):s1–13.

    Article  Google Scholar 

  2. Khaodhiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone. 1999;2(3):17–28.

    Article  CAS  PubMed  Google Scholar 

  3. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity. JAMA. 2013;311(1):1–13.

    Google Scholar 

  4. Heck AM, Yanovski JA, Calis KA. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy. 2000;20(3):270–9.

    Article  CAS  PubMed  Google Scholar 

  5. LeBlanc E, O’Connor E, Whitlock E, Patnode C, Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:434–47.

    Article  PubMed  Google Scholar 

  6. Jarl S, Mark N. XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care. 2004;27(1):155–61.

    Article  Google Scholar 

  7. Zhou Y-H, Ma X-Q, Wu C, et al. Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2012;7(6):e39062.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J. Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care. 1998;21(8):1288–94.

    Article  CAS  PubMed  Google Scholar 

  9. Bray GA, Ryan DH. Medical therapy for the patient with obesity. Circulation. 2012;125(13):1695–703.

    Article  PubMed  Google Scholar 

  10. Gustafson A, King C, Rey JA. Lorcaserin (Belviq): a selective Serotonin 5-HT2C agonist in the treatment of obesity. P T. 2013;38(9):525–34.

    PubMed  PubMed Central  Google Scholar 

  11. Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.

    Article  CAS  PubMed  Google Scholar 

  12. Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  13. O’Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM Study. Obesity. 2012;20(7):1426–36.

    Article  PubMed  Google Scholar 

  14. Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: past, current, and future therapies. J Obes. 2011;2011:179674.

    Article  PubMed  Google Scholar 

  15. Hampp C, Kang EM, Borders-Hemphill V. Use of prescription antiobesity drugs in the United States. Pharmacotherapy. 2013;33(12):1299–307.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Munro JF, MacCuish AC, Wilson EM, Duncan LJ. Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J. 1968;1(5588):352–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. National Institutes of Health. Gastrointestinal surgery for severe obesity. NIH Consens Statement Online. 1991;9(9):1–20.

    Google Scholar 

  18. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. Br Med J. 2013;347(oct22_1):f5934.

    Article  Google Scholar 

  19. Schauer P. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014;371(7):680–2.

    Article  Google Scholar 

  20. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.

    Article  PubMed  Google Scholar 

  21. Jackson TD, Hutter MM. Morbidity and effectiveness of laparoscopic sleeve gastrectomy, adjustable gastric band, and gastric bypass for morbid obesity. Adv Surg. 2012;46(1):255–68.

    Article  PubMed  Google Scholar 

  22. Deitel M, Gagner M, Erickson AL, Crosby RD. Third International Summit: current status of sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(6):749–59.

    Article  PubMed  Google Scholar 

  23. Felberbauer FX, Langer F, Shakeri-Manesch S, et al. Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: Intermediate-term results from a large series in three Austrian centers. Obes Surg. 2008;18(7):814–8.

    Article  PubMed  Google Scholar 

  24. Hutter M, Schirmer B, Jones D. First Report from the American College of Surgeons—Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–22.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Belachew M, Legrand M, Vincent V, et al. Laparoscopic placement of adjustable silicone gastric band in the treatment of morbid obesity: how to do it. Obes Surg. 1995;5(1):66–70.

    Article  PubMed  Google Scholar 

  26. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132(6):2253–71.

    Article  PubMed  Google Scholar 

  27. Finks JF, Kole KL, Yenumula PR, et al. Predicting risk for serious complications with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2011;254(4):633–40.

    Article  PubMed  Google Scholar 

  28. Boza C, Gamboa C, Perez G, et al. Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up. Surg Endosc. 2011;25(1):292–7.

    Article  PubMed  Google Scholar 

  29. Brunicardi CF, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE. Schwartz’s manual of surgery. 8th ed. New York: McGraw-Hill; 2006.

    Google Scholar 

  30. Zuegel NP, Lang RA, Hüttl TP, et al. Complications and outcome after laparoscopic bariatric surgery: LAGB versus LRYGB. Langenbecks Arch Surg. 2012;397(8):1235–41.

    Article  PubMed  Google Scholar 

  31. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119(3):261–8.

    Article  CAS  PubMed  Google Scholar 

  32. SAGES Guidelines Committee Society of American Gastrointestinal Endoscopic Surgeons. Guidelines for Clinical Application of Laparoscopic Bariatric Surgery SAGES Guidelines Committee. SAGES. 2008:1–31.

    Google Scholar 

  33. Chousleb E, Patel S, Szomstein S, Rosenthal R. Reasons and operative outcomes after reversal of gastric bypass and jejunoileal bypass. Obes Surg. 2012;22(10):1611–6.

    Article  PubMed  Google Scholar 

  34. Balsiger BM, Poggio JL, Mai J, Kelly KA, Sarr MG. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg. 2000;4(6):598–605.

    Article  CAS  PubMed  Google Scholar 

  35. Van Gemert WG, Van Wersch MM, Greve JWM, Soeters PB. Revisional surgery after failed vertical banded gastroplasty: restoration of vertical banded gastroplasty or conversion to gastric bypass. Obes Surg. 1998;8(1):21–8.

    Article  PubMed  Google Scholar 

  36. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E,Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C,Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209–2220.

    Google Scholar 

  37. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.

    Article  PubMed  Google Scholar 

  38. Maggard-Gibbons M, Maglione M, Livhits M, Ewing B, Maher AR, Hu J, Li Z, Shekelle PG. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes a systematic review. JAMA. 2013;309(21):2250–61.

    Article  CAS  PubMed  Google Scholar 

  39. Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, Biswas SK, Ramji S, Prabhakaran D, Reddy KS. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med. 2004;350(9):865–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy Jackson B.Sc, M.D, M.P.H, F.R.C.S .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Prabhu, K.L., Jackson, T. (2017). Overview of Medical and Surgical Treatment of Severe Obesity. In: Sockalingam, S., Hawa, R. (eds) Psychiatric Care in Severe Obesity. Springer, Cham. https://doi.org/10.1007/978-3-319-42536-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42536-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42534-4

  • Online ISBN: 978-3-319-42536-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics